Company:  NEUROCRINE BIOSCIENCES IN ... (NBIX)
Form Type:  8-K
Filing Date:  2/8/2013 
CIK:  0000914475 
Address:  12780 EL CAMINO REAL 
City, State, Zip:  SAN DIEGO, California 92130 
Telephone:  (858) 617-7600 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$13.79  
Change: 
0.01 (0.07%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$1.05B
Description of Business
We were originally incorporated in California in January 1992 and were reincorporated in Delaware in May 1996. We discover and develop innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through our novel R&D platform, focused on neurological and endocrine based diseases and disorders. Our two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone (GnRH) antagonist for women�s health that is partnered with AbbVie Inc. (AbbVie), and a wholly owned vesicular monoamine transporter 2 (VMAT2) inhibitor for the treatment of movement disorders. We intend to maintain certain commercial rights to our VMAT2 inhibitor and evolve into a fully-integrated pharmaceutical company.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 99.1
    INCOME STATEMENT
    BALANCE SHEET
BROKERAGE PARTNERS